Literature DB >> 1634041

Leber's hereditary optic neuropathy: a model for mitochondrial neurodegenerative diseases.

M D Brown1, A S Voljavec, M T Lott, I MacDonald, D C Wallace.   

Abstract

A number of human diseases have been attributed to defects in oxidative phosphorylation (OXPHOS) resulting from mutations in the mitochondrial DNA (mtDNA). One such disease is Leber's hereditary optic neuropathy (LHON), a neurodegenerative disease of young adults that results in blindness due to atrophy of the optic nerve. The etiology of LHON is genetically heterogeneous and in some cases multifactorial. Eleven mtDNA mutations have been associated with LHON, all of which are missense mutations in the subunit genes for the subunits of the electron transport chain complexes I, III, and IV. Molecular, biochemical, and population genetic studies have categorized these mutations as high risk (class I), low risk (class II), or intermediate risk (class I/II). Class I mutations appear to be primary genetic causes of LHON, while class II mutations are frequently found associated with class I genotypes and may serve as exacerbating genetic factors. Different LHON pedigrees can harbor different combinations of class I, II, or I/II mtDNA mutations, as shown by the complete sequence analysis of the mtDNAs of four LHON probands. The various mtDNA genotypes included an isolated class I mutation, combined class I+II mutations, and combined class I/II+II mutations. The occurrence of such genotypes supports the hypothesis that LHON may result from the additive effects of various genetic and environmental insults to OXPHOS, each of which increases the probability of blindness.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1634041     DOI: 10.1096/fasebj.6.10.1634041

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  43 in total

1.  Predominance of the T14484C mutation in French-Canadian families with Leber hereditary optic neuropathy is due to a founder effect.

Authors:  C Macmillan; T A Johns; K Fu; E A Shoubridge
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy.

Authors:  K Tsao; P A Aitken; D R Johns
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

3.  Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort.

Authors:  Anita Lakatos; Olga Derbeneva; Danny Younes; David Keator; Trygve Bakken; Maria Lvova; Marty Brandon; Guia Guffanti; Dora Reglodi; Andrew Saykin; Michael Weiner; Fabio Macciardi; Nicholas Schork; Douglas C Wallace; Steven G Potkin
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

4.  Mitochondrial genetics: principles and practice.

Authors:  J M Shoffner; D C Wallace
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

5.  Characterization of basal ganglia dysfunction in Leber 'plus' disease.

Authors:  C O Hanemann; H Hefter; G Schlaug; R J Seitz; H J Freund; R Benecke
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

Review 6.  Glaucoma genetics.

Authors:  Pratap Challa
Journal:  Int Ophthalmol Clin       Date:  2008

7.  Intracellular heteroplasmy for disease-associated point mutations in mtDNA: implications for disease expression and evidence for mitotic segregation of heteroplasmic units of mtDNA.

Authors:  P M Matthews; R M Brown; K Morten; D Marchington; J Poulton; G Brown
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

8.  Compensatory elevation of complex II activity in Leber's hereditary optic neuropathy.

Authors:  M Y Yen; H C Lee; J H Liu; Y H Wei
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

9.  Cobalt-chromium toxic retinopathy case study.

Authors:  Warren Apel; Denis Stark; Anthony Stark; Stephen O'Hagan; Joseph Ling
Journal:  Doc Ophthalmol       Date:  2012-12-15       Impact factor: 2.379

10.  Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia.

Authors:  D D De Vries; L N Went; G W Bruyn; H R Scholte; R M Hofstra; P A Bolhuis; B A van Oost
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.